🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

🔥 Interesting pre-print on how Chk1-Sp1-CD59 axis impedes rituximab mediated complement-dependent cytotoxicity biorxiv.org/content/10.110… Congratulations to the team! Anand D Jeyasekharan [email protected] NCIS CSI Singapore Chng Wee Joo

Yesterday, CSI Singapore hosted an in-person CSI Seminar Series with speaker - Prof. Yasuhiro Murakawa, from Kyoto University. He spoke on the topic “Harnessing Functional Genomics to Elucidate Cancer-specific RNAs and their Regulation”. WPI-ASHBi Kyoto University

🧬 The Chk1-Sp1-CD59 axis weakens rituximab ability to kill lymphoma cells by impairing Complement-dependent cytotoxicity. Targeting this pathway could enhance chemoimmunotherapy outcomes. CSI Singapore Anand D Jeyasekharan 🔬#Complement #Immunotherapy #DLBCL Link: doi.org/10.1101/2025.0…

Today, CSI Singapore hosted an in-person CSI Distinguished Speakers' Series with speaker - Prof. Seishi Ogawa, from Kyoto University, Japan. He spoke on the topic "Distinct Roles of Wnt Pathway Mutations in Colorectal Cancer" WPI-ASHBi Kyoto University

🌍 Happy International Women’s Day! 🌸 At CSI Singapore we’re proud to support our female research students who are pushing boundaries, driving innovation, and shaping the future of science and discovery. Let’s continue to inspire, break barriers, and make a lasting impact! 💪💡

Today, CSI Singapore hosted an in-person CSI Seminar Series with speaker - Prof. Andrew Hsieh, from Fred Hutch Cancer Center. He spoke on the topic “mRNA Translation in Cancer Etiology”. Hsieh Lab #csisingapore #cancerresearch #cancerresearchinstitute #mRNA #mRNATechnology

#RelayForLifeSG – We did it! 🎉 100km completed!!! 💪💪 Huge shoutout to all our amazing participants—your dedication and team spirit made this possible! With teamwork, anything is achievable! 🔥💜 instagram.com/p/DG9leQgTepv/…

Warmest congratulations to Professor Ashok Venkitaraman, Director of CSI Singapore, who is among 33 distinguished scientists from around the world elected to the 2025 class of Fellows of the American Association for Cancer Research (AACR) AACR!

In this 'A Model for Life' interview, we discuss Ashok Venkitaraman's outstanding research journey, how this translates to tangible clinical outcomes and how these outcomes can be shared globally. CSI Singapore Yong Loo Lin School of Medicine doi.org/10.1242/dmm.05…

Congratulations to our Director Professor Ashok Venkitaraman for the launch of the new S$130 million national research initiative, known as the National Initiative for RNA Biology and Its Applications (NIRBA). news.nus.edu.sg/new-national-i…

Gear up for Singapore’s esteemed cancer conference, Frontiers in Cancer Science 2025⭐️ #FCS2025 will be taking place from 5 to 7 Nov 2025. Abstract submission and registration will OPEN ON 1 MAY 2025. Learn more: csi.nus.edu.sg/fcs/

New breakthrough combats lenalidomide resistance in multiple myeloma news.nus.edu.sg/combating-lena…

We would like to congratulate our CSI PIs, Chng Wee Joo PLCLab_NUS & team!

Ready to take your research to the next level? Apply now for CSI Postdoctoral Fellowship and unlock new opportunities for growth and discovery!

Congratulations to Assistant Professor Anand Jeyasekharan for being accepted into AACR Annual Annual Meeting 2025 's NEXTGEN STARS Program! #AACR25

We’re excited to be at #AACR25! Join us at the Career Fair today, and visit our exhibit booth (3707) starting tomorrow. Come by and say hello!

Huge congratulations to our Director, Prof. Ashok Venkitaraman, on his induction to the AACR Academy at #AACR25! Honored for pioneering work on BRCA2, cancer mechanisms, and advancing drug discovery. #CancerResearch #AACR

2 days left to the opening of registration and abstract submission for #FCS2025 on 1 May! ⏰

Exciting news from our Director, Professor Ashok Venkitaraman. His lab's groundbreaking findings published in Molecular Cell 🔗 Read the full study: cell.com/molecular-cell…